Get notified when MD files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: MD Pediatrix Medical Group, Inc. 8-K

Pediatrix Medical Group announces General Counsel transition; Moore to depart Oct 31

Filed July 24, 2026 · Period ending July 21, 2026 · ~1 min read

Key Changes

  • medium

    Mary Ann E. Moore, EVP, General Counsel, Chief Administrative Officer and Secretary, will depart effective October 31, 2026 after serving in an advisory role through the transition period. Separation structured as termination without cause under her employment agreement.

    Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
  • medium

    David Haddock appointed as Executive Vice President, General Counsel and Secretary. The filing does not disclose his background, prior experience, start date, or compensation terms.

    Item 7.01 — Regulation FD Disclosure verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (SMMT 10-Q) is open in full — no account needed.

Partner

Trade MD commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jul 27, 2026 · How we verify